nodes	percent_of_prediction	percent_of_DWPC	metapath
Captodiame—DRD3—Parkinson's disease	0.884	1	CbGaD
Captodiame—DRD3—telencephalic ventricle—Parkinson's disease	0.0113	0.295	CbGeAlD
Captodiame—HTR2C—telencephalic ventricle—Parkinson's disease	0.0063	0.164	CbGeAlD
Captodiame—HTR2C—brainstem—Parkinson's disease	0.00171	0.0445	CbGeAlD
Captodiame—DRD3—head—Parkinson's disease	0.00169	0.0442	CbGeAlD
Captodiame—HTR2C—forebrain—Parkinson's disease	0.00165	0.0429	CbGeAlD
Captodiame—DRD3—nervous system—Parkinson's disease	0.00161	0.0419	CbGeAlD
Captodiame—DRD3—central nervous system—Parkinson's disease	0.00155	0.0403	CbGeAlD
Captodiame—DRD3—brain—Parkinson's disease	0.00123	0.032	CbGeAlD
Captodiame—HTR2C—medulla oblongata—Parkinson's disease	0.00119	0.031	CbGeAlD
Captodiame—SIGMAR1—medulla oblongata—Parkinson's disease	0.00112	0.0292	CbGeAlD
Captodiame—HTR2C—midbrain—Parkinson's disease	0.00109	0.0283	CbGeAlD
Captodiame—HTR2C—spinal cord—Parkinson's disease	0.00106	0.0277	CbGeAlD
Captodiame—SIGMAR1—midbrain—Parkinson's disease	0.00102	0.0267	CbGeAlD
Captodiame—SIGMAR1—spinal cord—Parkinson's disease	0.000999	0.026	CbGeAlD
Captodiame—HTR2C—head—Parkinson's disease	0.000943	0.0246	CbGeAlD
Captodiame—HTR2C—Monoamine GPCRs—HTR1A—Parkinson's disease	0.000931	0.0128	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—DRD2—Parkinson's disease	0.000908	0.0125	CbGpPWpGaD
Captodiame—DRD3—Monoamine GPCRs—HTR7—Parkinson's disease	0.000908	0.0125	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000902	0.0124	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD1—Parkinson's disease	0.000899	0.0124	CbGpPWpGaD
Captodiame—HTR2C—nervous system—Parkinson's disease	0.000894	0.0233	CbGeAlD
Captodiame—DRD3—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000872	0.012	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—DRD3—Parkinson's disease	0.000871	0.012	CbGpPWpGaD
Captodiame—HTR2C—central nervous system—Parkinson's disease	0.00086	0.0224	CbGeAlD
Captodiame—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—Parkinson's disease	0.000823	0.0113	CbGpPWpGaD
Captodiame—SIGMAR1—cerebellum—Parkinson's disease	0.000792	0.0206	CbGeAlD
Captodiame—HTR2C—Monoamine GPCRs—DRD2—Parkinson's disease	0.000787	0.0108	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—HTR7—Parkinson's disease	0.000787	0.0108	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—HTR1A—Parkinson's disease	0.000782	0.0108	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000763	0.0105	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000763	0.0105	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD1—Parkinson's disease	0.000756	0.0104	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD3—Parkinson's disease	0.000732	0.0101	CbGpPWpGaD
Captodiame—HTR2C—brain—Parkinson's disease	0.000683	0.0178	CbGeAlD
Captodiame—HTR2C—Amine ligand-binding receptors—HTR7—Parkinson's disease	0.000662	0.0091	CbGpPWpGaD
Captodiame—HTR2C—Amine ligand-binding receptors—DRD2—Parkinson's disease	0.000662	0.0091	CbGpPWpGaD
Captodiame—SIGMAR1—brain—Parkinson's disease	0.000643	0.0168	CbGeAlD
Captodiame—DRD3—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000636	0.00874	CbGpPWpGaD
Captodiame—Chlorphenamine—SLC6A3—Parkinson's disease	0.000608	0.136	CrCbGaD
Captodiame—HTR2C—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.000575	0.0079	CbGpPWpGaD
Captodiame—HTR2C—Monoamine GPCRs—HTR2A—Parkinson's disease	0.000551	0.00758	CbGpPWpGaD
Captodiame—Tripelennamine—CYP2D6—Parkinson's disease	0.00055	0.123	CrCbGaD
Captodiame—DRD3—GPCRs, Other—ADORA2A—Parkinson's disease	0.00055	0.00755	CbGpPWpGaD
Captodiame—DRD3—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000535	0.00735	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.000514	0.00707	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000513	0.00704	CbGpPWpGaD
Captodiame—Carbinoxamine—CYP2E1—Parkinson's disease	0.000512	0.114	CrCbGaD
Captodiame—HTR2C—Amine ligand-binding receptors—HTR2A—Parkinson's disease	0.000464	0.00637	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.000444	0.00611	CbGpPWpGaD
Captodiame—Brompheniramine—CYP2E1—Parkinson's disease	0.000444	0.0991	CrCbGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000439	0.00603	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—GRK5—Parkinson's disease	0.000436	0.00599	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Other—HTR7—Parkinson's disease	0.000403	0.00554	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—DDC—Parkinson's disease	0.000391	0.00537	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.00039	0.00535	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.000381	0.00523	CbGpPWpGaD
Captodiame—Carbinoxamine—CYP2D6—Parkinson's disease	0.000376	0.084	CrCbGaD
Captodiame—Promazine—DRD1—Parkinson's disease	0.000376	0.0839	CrCbGaD
Captodiame—DRD3—G alpha (i) signalling events—GRM4—Parkinson's disease	0.000375	0.00516	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—PENK—Parkinson's disease	0.000356	0.00489	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GPR37—Parkinson's disease	0.000334	0.0046	CbGpPWpGaD
Captodiame—Brompheniramine—CYP2D6—Parkinson's disease	0.000326	0.0727	CrCbGaD
Captodiame—DRD3—G alpha (i) signalling events—PDYN—Parkinson's disease	0.000325	0.00447	CbGpPWpGaD
Captodiame—Chlorphenamine—CYP2D6—Parkinson's disease	0.00032	0.0714	CrCbGaD
Captodiame—HTR2C—G alpha (q) signalling events—GRM5—Parkinson's disease	0.000315	0.00433	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—ADORA2A—Parkinson's disease	0.000292	0.00401	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GPR37—Parkinson's disease	0.00029	0.00398	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000283	0.00389	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Other—HTR2A—Parkinson's disease	0.000283	0.00388	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.000282	0.00387	CbGpPWpGaD
Captodiame—Orphenadrine—CYP2E1—Parkinson's disease	0.000279	0.0624	CrCbGaD
Captodiame—Promazine—DRD2—Parkinson's disease	0.000265	0.0592	CrCbGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000259	0.00356	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.000245	0.00337	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—DRD1—Parkinson's disease	0.000244	0.00336	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000239	0.00328	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—TAC1—Parkinson's disease	0.000229	0.00315	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GRM4—Parkinson's disease	0.000227	0.00312	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.000224	0.00308	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—HTR1A—Parkinson's disease	0.000223	0.00307	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—TH—Parkinson's disease	0.000218	0.00299	CbGpPWpGaD
Captodiame—Diphenhydramine—CYP2D6—Parkinson's disease	0.000217	0.0485	CrCbGaD
Captodiame—DRD3—GPCR ligand binding—PENK—Parkinson's disease	0.000215	0.00296	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—HTR7—Parkinson's disease	0.000214	0.00294	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—DRD2—Parkinson's disease	0.000214	0.00294	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.000207	0.00285	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.000207	0.00285	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.000205	0.00281	CbGpPWpGaD
Captodiame—Promazine—HTR2A—Parkinson's disease	0.000205	0.0457	CrCbGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000205	0.00281	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.000203	0.00279	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.0002	0.00275	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GRM4—Parkinson's disease	0.000197	0.00271	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—PDYN—Parkinson's disease	0.000197	0.00271	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000189	0.0026	CbGpPWpGaD
Captodiame—DRD3—G alpha (i) signalling events—DRD2—Parkinson's disease	0.000189	0.0026	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—PENK—Parkinson's disease	0.000187	0.00257	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—GRM5—Parkinson's disease	0.000183	0.00252	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.000182	0.00249	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00018	0.00247	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000178	0.00244	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.000177	0.00244	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000175	0.00241	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000175	0.00241	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000175	0.0024	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.000173	0.00238	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DGKQ—Parkinson's disease	0.000172	0.00236	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GPR37—Parkinson's disease	0.000172	0.00236	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000171	0.00236	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—PDYN—Parkinson's disease	0.000171	0.00235	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.000168	0.00231	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DGKQ—Parkinson's disease	0.000164	0.00225	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—GRM5—Parkinson's disease	0.000159	0.00218	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—EDN1—Parkinson's disease	0.000157	0.00216	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000157	0.00216	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000156	0.00214	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000154	0.00212	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000152	0.00209	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000152	0.00209	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000152	0.00208	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00015	0.00206	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00015	0.00206	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GPR37—Parkinson's disease	0.000149	0.00204	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DGKQ—Parkinson's disease	0.000149	0.00204	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000149	0.00204	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000144	0.00198	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GRK5—Parkinson's disease	0.000143	0.00197	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.000141	0.00193	CbGpPWpGaD
Captodiame—HTR2C—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.000138	0.00189	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000136	0.00187	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HTR1A—Parkinson's disease	0.000135	0.00186	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000135	0.00186	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—TAC1—Parkinson's disease	0.000133	0.00183	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—DRD1—Parkinson's disease	0.000131	0.00179	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.00013	0.00179	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.00013	0.00179	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GRK5—Parkinson's disease	0.00013	0.00179	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GRM4—Parkinson's disease	0.000128	0.00177	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GRK5—Parkinson's disease	0.000124	0.00171	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.000123	0.00169	CbGpPWpGaD
Captodiame—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000123	0.00169	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—VPS35—Parkinson's disease	0.000122	0.00168	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PENK—Parkinson's disease	0.000122	0.00167	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00012	0.00165	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR1A—Parkinson's disease	0.000117	0.00161	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GRM4—Parkinson's disease	0.000117	0.0016	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—TAC1—Parkinson's disease	0.000115	0.00159	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—DRD2—Parkinson's disease	0.000114	0.00157	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HTR7—Parkinson's disease	0.000114	0.00157	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD1—Parkinson's disease	0.000113	0.00156	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GRK5—Parkinson's disease	0.000113	0.00155	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GRM4—Parkinson's disease	0.000111	0.00153	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—PDYN—Parkinson's disease	0.000111	0.00153	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PENK—Parkinson's disease	0.000111	0.00152	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD3—Parkinson's disease	0.00011	0.00151	CbGpPWpGaD
Captodiame—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000106	0.00146	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—VPS35—Parkinson's disease	0.000106	0.00146	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PENK—Parkinson's disease	0.000106	0.00145	CbGpPWpGaD
Captodiame—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000105	0.00145	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000104	0.00143	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—GRM5—Parkinson's disease	0.000104	0.00142	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DGKQ—Parkinson's disease	0.000101	0.00139	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GPR37—Parkinson's disease	0.000101	0.00139	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GRM4—Parkinson's disease	0.000101	0.00139	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—PDYN—Parkinson's disease	0.000101	0.00139	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR7—Parkinson's disease	9.91e-05	0.00136	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—DRD2—Parkinson's disease	9.91e-05	0.00136	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—PDYN—Parkinson's disease	9.66e-05	0.00133	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PENK—Parkinson's disease	9.59e-05	0.00132	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—GRM5—Parkinson's disease	9.4e-05	0.00129	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PPP1R1B—Parkinson's disease	9.27e-05	0.00127	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—EDN1—Parkinson's disease	9.15e-05	0.00126	CbGpPWpGaD
Captodiame—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	9.12e-05	0.00125	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—GRM5—Parkinson's disease	8.98e-05	0.00123	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.8e-05	0.00121	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DGKQ—Parkinson's disease	8.79e-05	0.00121	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GPR37—Parkinson's disease	8.79e-05	0.00121	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—PDYN—Parkinson's disease	8.77e-05	0.00121	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—GRM5—Parkinson's disease	8.15e-05	0.00112	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—MAPK8—Parkinson's disease	8.15e-05	0.00112	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—RIT2—Parkinson's disease	8.1e-05	0.00111	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PPP1R1B—Parkinson's disease	8.04e-05	0.0011	CbGpPWpGaD
Captodiame—DRD3—GPCR ligand binding—HTR2A—Parkinson's disease	8.01e-05	0.0011	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADORA2A—Parkinson's disease	7.99e-05	0.0011	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—EDN1—Parkinson's disease	7.94e-05	0.00109	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GRK5—Parkinson's disease	7.68e-05	0.00106	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR1A—Parkinson's disease	7.64e-05	0.00105	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADORA2A—Parkinson's disease	7.63e-05	0.00105	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—TAC1—Parkinson's disease	7.52e-05	0.00103	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DRD1—Parkinson's disease	7.38e-05	0.00101	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—RIT2—Parkinson's disease	7.03e-05	0.000966	CbGpPWpGaD
Captodiame—HTR2C—GPCR ligand binding—HTR2A—Parkinson's disease	6.94e-05	0.000954	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR1A—Parkinson's disease	6.94e-05	0.000953	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADORA2A—Parkinson's disease	6.93e-05	0.000953	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GRM4—Parkinson's disease	6.89e-05	0.000947	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—TAC1—Parkinson's disease	6.83e-05	0.000939	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DRD1—Parkinson's disease	6.7e-05	0.000921	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.67e-05	0.000917	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GRK5—Parkinson's disease	6.66e-05	0.000915	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR1A—Parkinson's disease	6.62e-05	0.00091	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—MAG—Parkinson's disease	6.53e-05	0.000898	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PENK—Parkinson's disease	6.53e-05	0.000898	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—TAC1—Parkinson's disease	6.52e-05	0.000896	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR7—Parkinson's disease	6.46e-05	0.000888	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—DRD2—Parkinson's disease	6.46e-05	0.000888	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD1—Parkinson's disease	6.4e-05	0.000879	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD3—Parkinson's disease	6.2e-05	0.000851	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—ADRBK1—Parkinson's disease	6.06e-05	0.000833	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR1A—Parkinson's disease	6.01e-05	0.000827	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—PDYN—Parkinson's disease	5.97e-05	0.000821	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GRM4—Parkinson's disease	5.97e-05	0.000821	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—TAC1—Parkinson's disease	5.92e-05	0.000814	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR7—Parkinson's disease	5.87e-05	0.000806	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—DRD2—Parkinson's disease	5.87e-05	0.000806	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD1—Parkinson's disease	5.81e-05	0.000798	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—ADRBK1—Parkinson's disease	5.78e-05	0.000795	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—MAG—Parkinson's disease	5.66e-05	0.000778	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PENK—Parkinson's disease	5.66e-05	0.000778	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD3—Parkinson's disease	5.63e-05	0.000773	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GFAP—Parkinson's disease	5.62e-05	0.000772	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—DRD2—Parkinson's disease	5.6e-05	0.00077	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR7—Parkinson's disease	5.6e-05	0.00077	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—GRM5—Parkinson's disease	5.55e-05	0.000763	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—ADRBK1—Parkinson's disease	5.25e-05	0.000722	CbGpPWpGaD
Captodiame—DRD3—Circadian rythm related genes—IL6—Parkinson's disease	5.2e-05	0.000715	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—PDYN—Parkinson's disease	5.18e-05	0.000712	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—EDN1—Parkinson's disease	5.17e-05	0.000711	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—DRD2—Parkinson's disease	5.09e-05	0.000699	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR7—Parkinson's disease	5.09e-05	0.000699	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—FGF20—Parkinson's disease	4.87e-05	0.000669	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GFAP—Parkinson's disease	4.87e-05	0.000669	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—GRM5—Parkinson's disease	4.82e-05	0.000662	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADORA2A—Parkinson's disease	4.72e-05	0.000649	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—EDN1—Parkinson's disease	4.7e-05	0.000646	CbGpPWpGaD
Captodiame—DRD3—GPCR downstream signaling—HTR2A—Parkinson's disease	4.53e-05	0.000622	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—EDN1—Parkinson's disease	4.49e-05	0.000616	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—INSR—Parkinson's disease	4.36e-05	0.000599	CbGpPWpGaD
Captodiame—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.27e-05	0.000587	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—FGF20—Parkinson's disease	4.22e-05	0.00058	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—FGB—Parkinson's disease	4.12e-05	0.000566	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—HTR2A—Parkinson's disease	4.11e-05	0.000565	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR1A—Parkinson's disease	4.1e-05	0.000563	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADORA2A—Parkinson's disease	4.09e-05	0.000563	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—EDN1—Parkinson's disease	4.07e-05	0.00056	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—TAC1—Parkinson's disease	4.04e-05	0.000555	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DRD1—Parkinson's disease	3.96e-05	0.000544	CbGpPWpGaD
Captodiame—HTR2C—GPCR downstream signaling—HTR2A—Parkinson's disease	3.92e-05	0.000539	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—INSR—Parkinson's disease	3.78e-05	0.000519	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—ADRBK1—Parkinson's disease	3.58e-05	0.000492	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—FGB—Parkinson's disease	3.57e-05	0.000491	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	3.56e-05	0.00049	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	3.55e-05	0.000488	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	3.5e-05	0.000481	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—DRD2—Parkinson's disease	3.47e-05	0.000476	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR7—Parkinson's disease	3.47e-05	0.000476	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	3.43e-05	0.000472	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	3.32e-05	0.000457	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	3.1e-05	0.000426	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	3.01e-05	0.000413	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	3.01e-05	0.000413	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IGF2—Parkinson's disease	2.9e-05	0.000399	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IGF1R—Parkinson's disease	2.81e-05	0.000386	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—EDN1—Parkinson's disease	2.78e-05	0.000381	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—NGF—Parkinson's disease	2.55e-05	0.00035	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	2.52e-05	0.000346	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	2.44e-05	0.000335	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—HTR2A—Parkinson's disease	2.43e-05	0.000334	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	2.41e-05	0.000331	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—APOE—Parkinson's disease	2.26e-05	0.00031	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—NGF—Parkinson's disease	2.21e-05	0.000304	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	2.1e-05	0.000289	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—APOE—Parkinson's disease	1.96e-05	0.000269	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—INS—Parkinson's disease	1.93e-05	0.000265	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—INS—Parkinson's disease	1.67e-05	0.00023	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—CASP3—Parkinson's disease	1.44e-05	0.000197	CbGpPWpGaD
Captodiame—DRD3—Signaling by GPCR—IL6—Parkinson's disease	1.43e-05	0.000196	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	1.32e-05	0.000181	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	1.24e-05	0.000171	CbGpPWpGaD
Captodiame—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	1.24e-05	0.00017	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	1.14e-05	0.000157	CbGpPWpGaD
Captodiame—DRD3—Signaling Pathways—IL6—Parkinson's disease	8.43e-06	0.000116	CbGpPWpGaD
Captodiame—HTR2C—Signaling Pathways—IL6—Parkinson's disease	7.31e-06	0.0001	CbGpPWpGaD
